GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

The Philadelphia Department of Public Health has released its 2023 Annual Report on Hepatitis B, C, and D in the city. The ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

Chronic hepatitis B virus (HBV) infection imposes a severe burden on global public health. Currently, there are no curative therapies for millions of chronic HBV-infected patients (Lok et al., 2017).

Hepatitis B affects almost 300 million people worldwide, according to GSK, and while nucleoside/nucleotide analogue (NA) drugs to treat it are available – such as Gilead’s polymerase inhibitor ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

Many readers wrote to express their strong opposition to Robert F. Kennedy Jr.’s nomination to head the Department of Health and Human Services, which this week cleared a Senate committee vote and ...

[1] Since 1992, the inclusion of hepatitis B vaccination has been recommended by the WHO in all immunization programs implemented by nations. Indeed, the introduction of HBV vaccination in Europe ...

The Louisiana Republican, who led a hepatitis B vaccination campaign before entering politics, has expressed concerns about ...

Gonorrhoea is being flagged as an STD that spreads through unprotected sex. Women may encounter symptoms such as vaginal ...

That is about to change, with $6 million awarded to National Cancer Centre Singapore (NCCS) senior consultant surgeon Pierce ...